{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Vaxart, Inc."},"Symbol":{"label":"Symbol","value":"VXRT"},"Address":{"label":"Address","value":"170 HARBOR WAY,SUITE 300, SOUTH SAN FRANCISCO, California, 94080, United States"},"Phone":{"label":"Phone","value":"+1 650 550-3500"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States."},"CompanyUrl":{"label":"Company Url","value":"https://www.vaxart.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"James F. Cummings","title":"Chief Medical Officer"},{"name":"Raymond D. Stapleton","title":"Chief Technology Officer"},{"name":"Sean N. Tucker","title":"Chief Scientific Officer & Senior Vice President"},{"name":"Steven Lo","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}